School of Medicine


Showing 21-40 of 75 Results

  • Jacqueline Ferguson Solanki

    Jacqueline Ferguson Solanki

    Instructor (Affiliated), Health Policy
    Staff, Health Policy

    BioDr. Jacqueline Ferguson is a Research Investigator at the Palo Alto VA (Veterans Health Administration) and is a researcher with the Center for Population Health Sciences at Stanford Medicine.

    She specializes in using secondary data sources such as occupational records, insurance claims, and electronic health records to study the relationship between environmental, social exposures and population health. Her research interests are widespread, but all center around methodology to handle time-varying exposures affected by prior exposure and methodology to account for multiple co-exposures or exposure mixtures. Her most recent work has focused on improving access to care for Veterans by examining patient characteristics associated with the frequency, quantity, and proportion of video-based care used by Veterans.

    Jacqueline’s doctoral research at UC Berkeley and the Center for Population Health Sciences at Stanford Medicine has examined the impact of specific components of shift work on worker health, and identified night and rotational work as risk factors for hypertension and Type II diabetes. Jacqueline's current research seeks to understand how multiple social determinants of health can simultaneously influence Veteran care and health within the Veterans Health Administration.

    Complete List of Published Work: https://www.ncbi.nlm.nih.gov/myncbi/1xKgynf_jII5z/bibliography/public/

  • Zainab Garba-Sani

    Zainab Garba-Sani

    Affiliate, Health Policy

    BioZainab Garba-Sani is a Stanford-affiliated Research Scholar and UK Commonwealth Fund Senior Harkness Fellow (2022–23), working at the intersection of health policy, science, and community-centred practice. Her work focuses on how emerging fields such as artificial intelligence, genomics, and regenerative medicine can be translated responsibly into real-world health impact—particularly for underserved populations and people living with chronic and rare conditions.

    Her research and practice are grounded in bridging cutting-edge science and innovation with lived experience, with a focus on inclusive design, governance, and real-world implementation. She is the founder of ACCESS AI, an initiative advancing equitable and inclusive approaches to health AI through diverse community engagement, meaningful co-production, and interdisciplinary collaboration. Through this work, she contributes to broader conversations on AI governance, data equity, and the societal implications of innovation.

    Alongside this, Garba-Sani collaborates internationally with academic institutions, healthcare systems, civil society, industry, and governments to strengthen innovation pathways and care models for sickle cell and other historically neglected populations, including in low-and middle- income countries. She holds senior advisory and leadership roles across health and research ecosystems, including Vice Chair of the UK Sickle Cell Society, Founding Chair of NHS England’s Sickle Cell Transformation Patient Advisory Group, Co-Chair of Genomics England’s Diverse Data Advisory Board, and advisor to multiple committees focused on gene and cell therapies, regenerative medicine, health equity and rare diseases.

    She holds an MSc in Health Policy from Imperial College London and brings extensive experience in healthcare leadership, having previously served in senior roles at NHS England, TEDxNHS, and the NHS Muslim Network. Her contributions have been recognised with numerous awards, including the UK Prime Minister’s Points of Light Award.

  • Alan M. Garber

    Alan M. Garber

    Henry J. Kaiser Jr. Professor and Professor of Medicine, Emeritus

    Current Research and Scholarly InterestsTopics in the health economics of aging; health, insurance; optimal screening intervals; cost-effectiveness of, coronary surgery in the elderly; health care financing and delivery, in the United States and Japan; coronary heart disease

  • Jeremy Goldhaber-Fiebert

    Jeremy Goldhaber-Fiebert

    Professor of Health Policy

    BioJeremy Goldhaber-Fiebert, PhD, is a Professor of Health Policy and a Core Faculty Member in the Centers for Health Policy and Primary Care and Outcomes Research. His research focuses on complex policy decisions surrounding the prevention and management of increasingly common, chronic diseases and the life course impact of exposure to their risk factors. In the context of both developing and developed countries including the US, India, China, and South Africa, he has examined chronic conditions including type 2 diabetes and cardiovascular diseases, human papillomavirus and cervical cancer, tuberculosis, and hepatitis C and on risk factors including smoking, physical activity, obesity, malnutrition, and other diseases themselves. He combines simulation modeling methods and cost-effectiveness analyses with econometric approaches and behavioral economic studies to address these issues. Dr. Goldhaber-Fiebert graduated magna cum laude from Harvard College in 1997, with an A.B. in the History and Literature of America. After working as a software engineer and consultant, he conducted a year-long public health research program in Costa Rica with his wife in 2001. Winner of the Lee B. Lusted Prize for Outstanding Student Research from the Society for Medical Decision Making in 2006 and in 2008, he completed his PhD in Health Policy concentrating in Decision Science at Harvard University in 2008. He was elected as a Trustee of the Society for Medical Decision Making in 2011 and Secretary/Treasurer in 2021.

    Past and current research topics:

    - Type 2 diabetes and cardiovascular risk factors: Randomized and observational studies in Costa Rica examining the impact of community-based lifestyle interventions and the relationship of gender, risk factors, and care utilization.

    -Cervical cancer: Model-based cost-effectiveness analyses and costing methods studies that examine policy issues relating to cervical cancer screening and human papillomavirus vaccination in countries including the United States, Brazil, India, Kenya, Peru, South Africa, Tanzania, and Thailand.

    - Measles, haemophilus influenzae type b, and other childhood infectious diseases: Longitudinal regression analyses of country-level data from middle and upper income countries that examine the link between vaccination, sustained reductions in mortality, and evidence of herd immunity.

    - Patient adherence: Studies in both developing and developed countries of the costs and effectiveness of measures to increase successful adherence. Adherence to cervical cancer screening as well as to disease management programs targeting depression and obesity is examined from both a decision-analytic and a behavioral economics perspective.

    - Simulation modeling methods: Research examining model calibration and validation, the appropriate representation of uncertainty in projected outcomes, the use of models to examine plausible counterfactuals at the biological and epidemiological level, and the reflection of population and spatial heterogeneity.

  • Mary Kane Goldstein

    Mary Kane Goldstein

    Professor of Health Policy, Emerita

    Current Research and Scholarly InterestsHealth services research in primary care and geriatrics: developing, implementing, and evaluating methods for clinical quality improvement. Current work includes applying health information technology to quality improvement through clinical decision support (CDS) integrated with electronic health records; encoding clinical knowledge into computable formats in automated knowledge bases; natural language processing of free text in electronic health records; analyzing multiple comorbidities

  • Steven Goodman

    Steven Goodman

    Professor of Epidemiology and Population Health, of Medicine (Primary Care and Population Health) and, by courtesy, of Health Policy

    Current Research and Scholarly InterestsI study issues relating to the representation and measurement of evidence in medical research and determinants of the reliability of biomedical research findings. I also do work in evidence synthesis, comparative effectiveness research, and the ethics of clinical research.

  • Britni Wilcher

    Britni Wilcher

    Affiliate, Health Policy
    Visiting Scholar, Health Policy

    BioBritni Wilcher, PhD, is a Visiting Scholar in the Department of Health Policy at Stanford University and an applied microeconomist working at the intersection of health, labor, and gender economics. Dr. Wilcher's research focuses on the economics of health decision making and its implications for labor markets using quasi-experimental designs. Her research portfolio spans vulnerable populations and policy interventions, from evaluating teletherapy adoption patterns among 200,000+ veterans to conducting regulatory impact analyses protecting 22+ million workers nationwide. Her collaborative research products have withstood judicial review up to the Supreme Court and provided evidence-based input into policy actions. Her work has been cited in congressional testimony and the 2022 Economic Report of the President. It has been featured in federal regulations and published in peer-reviewed journals including Labour Economics, Health Economics, Value in Health, and the International Journal of Technology Assessment in Health Care.

    Dr. Wilcher has worked in management consulting, government, universities, and has consulted with think tanks, foundations, the EU Commission, and a United Nations entity. She holds a PhD in Economics from American University, an MSc in International Health Care Management, Economics, and Policy from SDA Bocconi School of Management, and a BA in Economics from Spelman College.

  • Anna H Grummon

    Anna H Grummon

    Assistant Professor of Pediatrics (General Pediatrics) and, by courtesy, of Health Policy

    BioDr. Grummon is an Assistant Professor of Pediatrics and (by courtesy) Health Policy and the Director of the Stanford Food Policy Lab. Dr. Grummon is a behavioral scientist whose work seeks to identify and evaluate policies that encourage healthy eating and help children and their families live long, healthy lives. In her work, Dr. Grummon uses randomized trials, natural experiments, and simulation modeling to examine how food policies like warning labels, beverage taxes, and food assistance programs affect what we eat and how healthy we are. She also studies strategies for encouraging people to choose foods that are more environmentally sustainable. Dr. Grummon's program of research has been funded by the National Institutes of Health, the Robert Wood Johnson Foundation, the New York City Department of Health and Mental Hygiene, and others. Her work has been published in leading medical and public health journals including JAMA, New England Journal of Medicine, Science, and the American Journal of Public Health and received coverage in news outlets such as the New York Times, the Washington Post, NBC, NPR, and Forbes.

    Dr. Grummon holds a PhD and MSPH in Health Behavior from the University of North Carolina Gillings School of Global Public Health and a BA with Honors in Human Biology from Stanford. She completed her postdoctoral training at Harvard.

  • Mark Hlatky, MD

    Mark Hlatky, MD

    Professor of Health Policy, of Medicine (Cardiovascular Medicine) and, by courtesy, of Epidemiology and Population Health

    Current Research and Scholarly InterestsMy main research work is in "outcomes research", especially examining the field of cardiovascular medicine. Particular areas of interest are the integration of economic and quality of life data into randomized clinical trials, evidence-based medicine, decision models, and cost-effectiveness analysis. I am also interested in the application of novel genetic, biomarker, and imaging tests to assess risk and guide clinical management of coronary artery disease.

  • Erin Eanes Holsinger

    Erin Eanes Holsinger

    Lecturer, Health Policy - HP/PCOR
    Clinical Assistant Professor, Pediatrics - General Pediatrics

    BioErin Holsinger is a Lecturer in the Department of Health Policy and a Clinical Assistant Professor in the Department of Pediatrics. In Health Policy, she is a co-director of the Health Services and Policy Research Scholarly Concentration in the School of Medicine and the Administrative Director of the Health Policy MS and PhD programs. In Pediatrics, she is an attending physician at the Gardner Packard Children’s Health Clinic. She is a member of Stanford’s LongSHOT (Longitudinal Study of Handgun Ownership and Transfer) team and performs research about the impact of gun ownership on the risk of death for the gun owner and those who live with them.

  • Keith Humphreys

    Keith Humphreys

    Esther Ting Memorial Professor and Professor, by courtesy, of Health Policy

    Current Research and Scholarly InterestsDr. Humphreys researches individual and societal level interventions for addictive and psychiatric disorders. He focuses particularly on evaluating the outcomes of professionally-administered treatments and peer-operated self-help groups (e.g., Alcoholics Anonymous), and, analyzing the impact of public policies touching addiction, mental health, public health, and public safety.

  • Bob Kocher

    Bob Kocher

    Adjunct Professor, Health Policy

    BioBob Kocher, MD is a Partner at Venrock and focuses on healthcare IT and services investments. He currently serves on the Boards of Devoted Health, Virta Health, Aledade, Lyra Health, Sitka, Need, Accompany Health, and Premera Blue Cross. He is a Board Observer at SmithRx, Stride, Suki, and The Public Health Company and previously Included Health (Grand Rounds + Doctor on Demand) and Castlight.

    He is an Adjunct Professor at Stanford University School of Medicine and a Non-Resident Senior Fellow and Advisory Board Member at the Leonard D. Schaeffer Center for Health Policy and Economics at USC. He also serves on the Advisory Board of the National Institute of Healthcare Management (NIHCM).

    Previously, Bob served in the Obama Administration as Special Assistant to the President for Healthcare and Economic Policy on the National Economic Council, as a Partner at McKinsey & Company, and is an internal medicine doctor.

  • Mario Martinez-Jimenez

    Mario Martinez-Jimenez

    Affiliate, Health Policy
    Visiting Postdoctoral Scholar, Health Policy

    BioMario Martínez-Jiménez is a Visiting Postdoctoral Scholar in the Department of Health Policy at Stanford Medicine, hosted by Dr. Maya Rossin-Slater. He is an applied microeconomist whose research focuses on the economics of child development and human capital formation, with an emphasis on how early-life conditions and policy shape long-run outcomes.

    Mario’s primary affiliation is with the Department of Economics & Public Policy at Imperial College Business School, where he is an Imperial College Research Fellow.

    He received his PhD in Economics of Health from Lancaster University. He also has a Bachelor of Science in Economics from the Pompeu Fabra University (UPF), a Master of Science in Health Economics from the Erasmus University Rotterdam (EUR), and a Master of Research in Applied Economics from the Autonomous University of Barcelona (UAB).



    SU email: mmarjim3@stanford.edu